“…The most frequently mutated SDH genes are SDHB and SDHD , with only a few mutations detected in SDHC , whereas SDHA or SDHAF genes are rarely mutated (Kim et al , ; Tretter, Patocs, & Chinopoulos, ). Besides the mutational status of SDH subunits, it is emerging that SDH expression/activity might also be regulated: ( i ) at a transcriptional or post‐transcriptional level, by epigenetic suppression of SDH subunit expression (Baysal, ; Richter et al , ), by RNA non‐sense mutation due to C‐to‐U RNA editing that has been demonstrated to reduce the SDHB functional transcript dynamically in monocytes (Baysal et al , ), and by the expression of microRNAs (miRNAs) targeting SDH messenger RNAs (mRNAs) (Eichner et al , ; Tsang et al , ; Lee et al , ); and ( ii ) at a post‐translational level, by the inhibition of SDH activity, for example through the binding of the chaperone tumour necrosis factor receptor‐associated protein 1 (TRAP‐1) (Sciacovelli et al , ) or through the competitive inhibition of the metabolite itaconate in activated macrophages (Lampropoulou et al , ), or by the regulation of SDH phosphorylation through protein tyrosine phosphatase mitochondrial 1 (PTPMT1) (Nath et al , ), feline Gardner‐Rasheed sarcoma viral oncogene homolog (Fgr) tyrosine kinase (Salvi et al , ), or avian sarcoma (Schmidt‐Ruppin A‐2) viral oncogene homolog (c‐Src) tyrosine kinase (Ogura et al , ).…”